LBIO Lion Biotechnologies, Inc.

7.15
-0.20  -3%
Previous Close 7.35
Open 7.35
Price To book 3.06
Market Cap 445.81M
Shares 62,351,000
Volume 681,657
Short Ratio 7.42
Av. Daily Volume 348,048

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 initiated March 2017.
LN-145
Head and neck cancer
Phase 2 second cohort commenced enrollment - May 19, 2017. Initial data presented at ASCO June 5, 2017.
LN-144
Refractory metastatic melanoma
Phase 2 initiated April 2017.
LN-145
Cervical cancer

Latest News

  1. DEADLINE TODAY: Lundin Law PC Announces Securities Class Action Lawsuit against Lion Biotechnologies, Inc. and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm
  2. LBIO DEADLINE TODAY: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Lion Biotechnologies, Inc. and a Lead Plaintiff Deadline of June 13, 2017
  3. FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lion Biotechnologies, Inc. (LBIO) & Lead Plaintiff Deadline: June 13, 2017
  4. DEADLINE TOMORROW: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Lion Biotechnologies, Inc. and Reminds Investors with Losses to Contact the Firm
  5. LBIO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Lion Biotechnologies, Inc. and a Lead Plaintiff Deadline of June 13, 2017
  6. JUNE 13 DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Lion Biotechnologies, Inc. and Reminds Investors with Losses to Contact the Firm
  7. INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Lion Biotechnologies, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 13, 2017 - LBIO
  8. DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lion Biotechnologies, Inc. (LBIO) & Lead Plaintiff Deadline: June 13, 2017
  9. DEADLINE TUESDAY: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Lion Biotechnologies, Inc. and Reminds Investors with Losses to Contact the Firm
  10. SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lion Biotechnologies, Inc. of Class Action Lawsuit and Upcoming Deadline - LBIO
  11. The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Lion Biotechnologies, Inc. Shareholders and a Lead Plaintiff Deadline of June 13, 2017
  12. DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Lion Biotechnologies, Inc. and Reminds Investors with Losses to Contact the Firm
  13. 5-DAY DEADLINE: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Lion Biotechnologies, Inc. and Reminds Investors with Losses to Contact the Firm
  14. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Lion Biotechnologies, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 13, 2017 - LBIO
  15. Scott+Scott, Attorneys at Law, LLP Reminds Investors of Upcoming Deadline to File Lead Plaintiff Papers in Lion Biotechnologies, Inc. (NASDAQ:LBIO) Securities Case
  16. INVESTOR REMINDER: Lundin Law PC Announces Securities Class Action Lawsuit against Lion Biotechnologies, Inc. and Reminds Investors with Losses to Contact the Firm
  17. The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Lion Biotechnologies, Inc. Shareholders and a Lead Plaintiff Deadline of June 13, 2017